Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (405)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
137
4.400
Why?
Vulvar Neoplasms
6
2024
58
2.710
Why?
Carcinoma, Squamous Cell
9
2024
326
2.160
Why?
Carcinoma in Situ
7
2022
73
1.900
Why?
Uterine Neoplasms
10
2023
60
1.900
Why?
Carcinoma, Endometrioid
6
2021
38
1.580
Why?
Adenocarcinoma
10
2024
397
1.530
Why?
Tumor Suppressor Protein p53
3
2024
213
1.460
Why?
PAX2 Transcription Factor
7
2015
22
1.410
Why?
Uterine Cervical Neoplasms
7
2024
276
1.160
Why?
Ovarian Neoplasms
10
2024
450
1.150
Why?
Endometrial Hyperplasia
4
2019
14
1.110
Why?
Cannabidiol
6
2024
40
1.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2024
59
1.060
Why?
Stromal Cells
2
2016
75
1.000
Why?
Female
66
2024
27081
0.900
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.870
Why?
Plant Extracts
6
2024
174
0.870
Why?
Myometrium
2
2013
13
0.830
Why?
Endometrium
6
2023
40
0.800
Why?
Adenocarcinoma, Clear Cell
6
2019
34
0.760
Why?
Precancerous Conditions
3
2019
82
0.740
Why?
Immunohistochemistry
16
2024
957
0.730
Why?
Cannabis
6
2024
146
0.730
Why?
Aged, 80 and over
20
2024
3226
0.700
Why?
Middle Aged
35
2024
12611
0.680
Why?
Humans
70
2024
50503
0.680
Why?
Cystadenocarcinoma, Serous
4
2013
71
0.670
Why?
Peripheral Nerves
2
2015
48
0.610
Why?
Mutation
9
2024
1280
0.580
Why?
Aged
29
2024
9741
0.570
Why?
Placenta
6
2021
134
0.560
Why?
Cervix Uteri
2
2017
42
0.550
Why?
Epithelial-Mesenchymal Transition
2
2016
51
0.550
Why?
Adult
31
2024
13577
0.540
Why?
Adenosarcoma
1
2016
3
0.530
Why?
Polyps
1
2016
20
0.520
Why?
Uterine Cervical Dysplasia
1
2016
49
0.510
Why?
Lymphatic Metastasis
6
2019
222
0.490
Why?
Neoplasm Staging
9
2024
746
0.490
Why?
Fibroma
1
2015
37
0.490
Why?
Papillomavirus Infections
3
2024
168
0.490
Why?
Fallopian Tubes
2
2012
22
0.490
Why?
Tumor Microenvironment
4
2021
222
0.480
Why?
Prognosis
11
2024
1978
0.440
Why?
Neoplasm Invasiveness
6
2019
269
0.430
Why?
Observer Variation
4
2024
139
0.430
Why?
Pelvic Neoplasms
1
2011
14
0.380
Why?
Uterus
3
2023
85
0.380
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
76
0.370
Why?
Mice, Inbred C57BL
7
2024
1808
0.350
Why?
Ejaculatory Ducts
1
2010
3
0.350
Why?
Seminal Vesicles
1
2010
13
0.350
Why?
Neoplasm Recurrence, Local
4
2015
629
0.340
Why?
Spectrum Analysis, Raman
2
2021
55
0.340
Why?
Reproducibility of Results
5
2024
1197
0.340
Why?
Prostate
1
2010
114
0.330
Why?
Mice
16
2024
5687
0.320
Why?
Bromcresol Purple
1
2009
3
0.320
Why?
Electrophoresis, Capillary
1
2009
10
0.320
Why?
Serum Albumin
1
2009
57
0.310
Why?
Human papillomavirus 16
2
2021
44
0.310
Why?
Methionine
2
2020
134
0.300
Why?
beta Catenin
2
2021
97
0.300
Why?
Disease Progression
4
2020
829
0.300
Why?
Predictive Value of Tests
5
2024
930
0.300
Why?
Liver
4
2024
1132
0.290
Why?
Diabetes Mellitus
2
2023
279
0.290
Why?
Genital Neoplasms, Female
2
2018
41
0.290
Why?
Papillomavirus Vaccines
2
2021
67
0.280
Why?
Anus Neoplasms
2
2018
24
0.280
Why?
Cell Proliferation
4
2021
985
0.280
Why?
Metaplasia
2
2019
15
0.280
Why?
Antigens, CD
2
2019
222
0.270
Why?
Diagnosis, Differential
8
2020
1033
0.270
Why?
Prostatic Neoplasms
1
2010
384
0.260
Why?
Colitis
2
2020
51
0.260
Why?
Polyethylene Glycols
2
2017
86
0.260
Why?
Melanoma
2
2020
280
0.260
Why?
Neoplasm Grading
5
2021
122
0.250
Why?
Animals
17
2024
13124
0.250
Why?
Hypertension
2
2021
544
0.250
Why?
Chi-Square Distribution
2
2016
277
0.240
Why?
Gold
2
2017
128
0.240
Why?
Proteomics
3
2017
314
0.240
Why?
Nanoparticles
2
2017
152
0.240
Why?
Aspartic Acid Endopeptidases
2
2015
16
0.230
Why?
Young Adult
7
2024
4102
0.230
Why?
Lab-On-A-Chip Devices
1
2024
9
0.230
Why?
Retrospective Studies
11
2020
6263
0.230
Why?
Racemases and Epimerases
2
2015
17
0.230
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
3
0.230
Why?
Carcinoma, Neuroendocrine
1
2024
23
0.220
Why?
Neuroendocrine Tumors
1
2024
23
0.220
Why?
DNA Mutational Analysis
3
2024
175
0.220
Why?
Head and Neck Neoplasms
2
2019
287
0.220
Why?
Kidney Neoplasms
2
2018
174
0.220
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
40
0.220
Why?
Homeodomain Proteins
1
2024
79
0.210
Why?
Chlamydia muridarum
1
2024
40
0.210
Why?
Lung Neoplasms
2
2019
601
0.210
Why?
Endometriosis
1
2023
14
0.210
Why?
Gynecology
2
2020
48
0.210
Why?
Chlamydia Infections
1
2024
75
0.210
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.210
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.200
Why?
Hepatocytes
2
2024
178
0.200
Why?
CD4-Positive T-Lymphocytes
1
2024
158
0.200
Why?
Fallopian Tube Neoplasms
2
2012
14
0.200
Why?
Immunotherapy
2
2021
235
0.200
Why?
Gestational Trophoblastic Disease
2
2012
2
0.190
Why?
Genotype
2
2021
533
0.190
Why?
CTLA-4 Antigen
1
2021
23
0.190
Why?
Fetal Membranes, Premature Rupture
1
2021
22
0.190
Why?
Oncogene Fusion
1
2021
4
0.190
Why?
Estrogens
2
2023
226
0.190
Why?
PTEN Phosphohydrolase
3
2020
53
0.190
Why?
Leiomyosarcoma
1
2021
20
0.180
Why?
Transcription Factors
3
2020
565
0.180
Why?
Diabetes, Gestational
1
2021
52
0.180
Why?
Cancer Vaccines
1
2021
80
0.180
Why?
Carcinosarcoma
2
2017
18
0.180
Why?
Infant, Small for Gestational Age
1
2020
32
0.170
Why?
Carcinoma, Papillary
1
2020
47
0.170
Why?
Neoplasms, Experimental
1
2020
110
0.170
Why?
Carcinoma, Transitional Cell
1
2020
51
0.170
Why?
Pregnancy in Diabetics
1
2020
26
0.170
Why?
Colonic Neoplasms
1
2021
158
0.170
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.170
Why?
Carcinoma, Lewis Lung
1
2019
9
0.170
Why?
Dermatology
1
2020
52
0.170
Why?
Radiotherapy
1
2020
125
0.170
Why?
Placenta Diseases
1
2019
13
0.170
Why?
Pregnancy Complications, Neoplastic
1
2019
23
0.170
Why?
Carcinoma, Renal Cell
2
2018
101
0.170
Why?
Skin Diseases
1
2020
112
0.160
Why?
Premature Birth
1
2021
146
0.160
Why?
Hepatic Veno-Occlusive Disease
1
2019
9
0.160
Why?
Odds Ratio
3
2015
551
0.160
Why?
Melanoma, Experimental
1
2019
40
0.160
Why?
DNA Polymerase II
1
2019
9
0.160
Why?
Hodgkin Disease
1
2019
47
0.160
Why?
T-Lymphocytes
1
2021
325
0.160
Why?
DNA Mismatch Repair
1
2019
16
0.160
Why?
Fetal Diseases
1
2019
57
0.160
Why?
Inflammation
2
2020
610
0.160
Why?
Sarcoma
1
2020
65
0.160
Why?
Pregnancy
7
2021
2452
0.160
Why?
Monocytes
1
2019
127
0.160
Why?
Urinary Bladder Neoplasms
1
2020
158
0.160
Why?
Metformin
1
2020
65
0.160
Why?
Methionine Adenosyltransferase
1
2018
19
0.150
Why?
CD8-Positive T-Lymphocytes
1
2019
125
0.150
Why?
Logistic Models
3
2015
900
0.150
Why?
Nuclear Proteins
1
2020
238
0.150
Why?
Disease Models, Animal
6
2020
1436
0.150
Why?
Radiation Tolerance
1
2019
84
0.150
Why?
Hypoglycemic Agents
1
2020
173
0.150
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.150
Why?
Rhabdomyosarcoma
1
2018
10
0.150
Why?
Programmed Cell Death 1 Receptor
1
2018
39
0.150
Why?
DNA Helicases
1
2020
146
0.150
Why?
Intestinal Mucosa
2
2020
216
0.150
Why?
Pathology, Molecular
1
2017
22
0.150
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
67
0.140
Why?
Biopsy
5
2020
588
0.140
Why?
Tumor Necrosis Factor-alpha
2
2019
393
0.140
Why?
Pregnancy Complications
1
2021
380
0.140
Why?
Osteosarcoma
1
2017
45
0.140
Why?
Neoplastic Cells, Circulating
1
2017
74
0.130
Why?
Vimentin
1
2016
32
0.130
Why?
Gene Expression Profiling
2
2019
1025
0.130
Why?
Time Factors
3
2021
2935
0.130
Why?
Papillomaviridae
1
2017
103
0.130
Why?
DNA-Binding Proteins
2
2016
418
0.130
Why?
Acetaminophen
1
2019
276
0.130
Why?
Oligonucleotide Array Sequence Analysis
1
2017
405
0.130
Why?
Cadherins
1
2016
63
0.130
Why?
Viral Load
1
2016
76
0.130
Why?
Male
11
2024
25907
0.120
Why?
Skin Neoplasms
1
2020
491
0.120
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.120
Why?
Neoplasms, Muscle Tissue
1
2015
11
0.120
Why?
Malate Dehydrogenase
1
2014
8
0.120
Why?
Colposcopy
1
2015
17
0.120
Why?
Classification
1
2015
14
0.120
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
17
0.120
Why?
Lipogenesis
1
2014
28
0.120
Why?
Flow Cytometry
1
2017
474
0.120
Why?
World Health Organization
1
2015
51
0.120
Why?
Cytosol
1
2014
78
0.120
Why?
Mice, Inbred BALB C
3
2021
296
0.120
Why?
Adolescent
4
2024
6443
0.120
Why?
Histones
1
2016
297
0.120
Why?
Neoplasm, Residual
1
2015
160
0.120
Why?
Mammary Neoplasms, Experimental
1
2015
121
0.120
Why?
Obesity
1
2022
1121
0.110
Why?
Multiple Myeloma
1
2009
2998
0.110
Why?
High-Throughput Nucleotide Sequencing
3
2021
169
0.110
Why?
Antineoplastic Agents
2
2021
1172
0.110
Why?
Gastrointestinal Tract
1
2014
103
0.110
Why?
Intestines
1
2014
172
0.110
Why?
Oncogenes
1
2013
57
0.110
Why?
Cell Line, Tumor
4
2020
1398
0.110
Why?
Patient Selection
1
2015
259
0.110
Why?
Clusterin
1
2012
6
0.100
Why?
Membrane Proteins
1
2015
332
0.100
Why?
Pancreatic Neoplasms
1
2015
206
0.100
Why?
Dose-Response Relationship, Drug
3
2024
1372
0.100
Why?
Risk Factors
3
2015
3724
0.100
Why?
Histocytochemistry
1
2012
44
0.100
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
22
0.100
Why?
Strongyloidiasis
1
2012
10
0.100
Why?
Follow-Up Studies
2
2016
2242
0.100
Why?
Treatment Outcome
3
2021
5283
0.100
Why?
Cytomegalovirus Infections
1
2012
38
0.100
Why?
Prednisone
1
2012
101
0.100
Why?
Vascular Endothelial Growth Factor A
1
2012
182
0.090
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
10
0.090
Why?
Teratoma
1
2011
22
0.090
Why?
Matrix Metalloproteinases
1
2011
46
0.090
Why?
Adenoma, Oxyphilic
1
2010
11
0.090
Why?
Sensitivity and Specificity
3
2020
859
0.090
Why?
Image Processing, Computer-Assisted
1
2012
243
0.090
Why?
Phenotype
3
2019
739
0.090
Why?
Tissue Array Analysis
3
2015
45
0.080
Why?
Glucocorticoids
1
2012
230
0.080
Why?
Tumor Cells, Cultured
2
2021
457
0.080
Why?
Epigenesis, Genetic
1
2012
372
0.080
Why?
Pregnancy Outcome
2
2021
207
0.080
Why?
Pilot Projects
2
2023
698
0.080
Why?
Infant, Newborn
3
2021
2749
0.080
Why?
Phosphatidylinositol 3-Kinases
2
2024
140
0.080
Why?
Necrosis
2
2024
174
0.080
Why?
Telemedicine
1
2015
469
0.080
Why?
Cell Differentiation
2
2024
640
0.080
Why?
Hysterectomy
2
2021
88
0.070
Why?
Cell Nucleus
2
2021
182
0.070
Why?
Societies, Medical
2
2019
187
0.070
Why?
Host-Pathogen Interactions
2
2021
135
0.070
Why?
Gene Expression Regulation
3
2023
955
0.070
Why?
Neoplasms
1
2017
1251
0.070
Why?
Consensus
2
2020
160
0.070
Why?
Ventricular Pressure
1
2006
16
0.070
Why?
Isoproterenol
1
2006
56
0.070
Why?
Terminology as Topic
2
2018
67
0.070
Why?
Kaplan-Meier Estimate
2
2018
464
0.070
Why?
Serum Response Factor
1
2006
40
0.070
Why?
Combined Modality Therapy
2
2020
641
0.070
Why?
Kidney
1
2010
696
0.060
Why?
Practice Guidelines as Topic
2
2019
468
0.060
Why?
Neoplasm Metastasis
2
2018
232
0.060
Why?
Cytokines
2
2020
606
0.060
Why?
Cells, Cultured
2
2021
1571
0.060
Why?
Proportional Hazards Models
2
2017
415
0.060
Why?
Chromatography, Liquid
2
2016
231
0.060
Why?
Bilirubin
1
2024
40
0.060
Why?
Tandem Mass Spectrometry
2
2016
238
0.060
Why?
Species Specificity
1
2024
187
0.060
Why?
Heart
1
2006
341
0.060
Why?
Steroids
1
2024
57
0.060
Why?
Th1 Cells
1
2024
53
0.050
Why?
Interleukin-10
1
2024
84
0.050
Why?
Phylogeny
1
2024
236
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2018
833
0.050
Why?
Government Agencies
1
2022
15
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
68
0.050
Why?
Hemorrhage
1
2024
197
0.050
Why?
Choriocarcinoma
2
2012
7
0.050
Why?
Genes, T-Cell Receptor
1
2021
5
0.050
Why?
Uterine Hemorrhage
1
2021
8
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
25
0.050
Why?
Parturition
1
2021
49
0.050
Why?
Phthalazines
1
2021
20
0.050
Why?
Remission Induction
1
2021
208
0.050
Why?
Quinazolines
1
2021
32
0.050
Why?
Lymphocyte Activation
1
2021
164
0.050
Why?
Vulva
1
2020
17
0.050
Why?
Taurine
1
2020
18
0.040
Why?
Research Report
1
2020
16
0.040
Why?
Metabolic Networks and Pathways
1
2021
92
0.040
Why?
Herb-Drug Interactions
1
2020
31
0.040
Why?
Mucin-2
1
2020
8
0.040
Why?
Toxicity Tests
1
2020
54
0.040
Why?
Alkaline Phosphatase
1
2020
93
0.040
Why?
Risk
1
2021
324
0.040
Why?
Molecular Targeted Therapy
1
2021
123
0.040
Why?
Piperazines
1
2021
119
0.040
Why?
United States
3
2016
4955
0.040
Why?
Chemokines
1
2020
75
0.040
Why?
Birth Weight
1
2020
106
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
572
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
Preoperative Period
1
2020
48
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
34
0.040
Why?
Endothelium
1
2019
37
0.040
Why?
Colon
1
2020
97
0.040
Why?
Pyrimidines
1
2021
191
0.040
Why?
Mice, Transgenic
2
2014
540
0.040
Why?
Chest Pain
1
2019
55
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
31
0.040
Why?
Receptors, Progesterone
1
2020
64
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
62
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
194
0.040
Why?
Glutamine
1
2020
175
0.040
Why?
Dyspnea
1
2019
75
0.040
Why?
Estrogen Receptor alpha
1
2020
88
0.040
Why?
Liver Function Tests
1
2019
45
0.040
Why?
Fatal Outcome
1
2019
197
0.040
Why?
Mice, Inbred Strains
1
2019
160
0.040
Why?
Drug Synergism
1
2019
151
0.040
Why?
Gestational Age
1
2020
373
0.040
Why?
Imaging, Three-Dimensional
1
2019
150
0.040
Why?
Mice, Nude
1
2019
248
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
212
0.040
Why?
Nephrectomy
1
2018
81
0.040
Why?
Mullerian Ducts
1
2018
4
0.040
Why?
Wolffian Ducts
1
2018
2
0.040
Why?
Mutation Rate
1
2018
35
0.040
Why?
Skin
1
2020
388
0.040
Why?
Lymph Node Excision
1
2019
131
0.040
Why?
Ultrasonography, Prenatal
1
2019
160
0.040
Why?
Cell Lineage
1
2018
83
0.040
Why?
Mixed Tumor, Mullerian
1
2017
3
0.040
Why?
DNA Copy Number Variations
1
2018
109
0.040
Why?
Anal Canal
1
2017
21
0.030
Why?
Macrophages
1
2019
364
0.030
Why?
Transcriptome
1
2019
313
0.030
Why?
Disease-Free Survival
1
2017
444
0.030
Why?
Lymph Nodes
1
2019
257
0.030
Why?
Dietary Supplements
1
2020
449
0.030
Why?
Child
2
2024
6906
0.030
Why?
Matrix Attachment Region Binding Proteins
1
2017
37
0.030
Why?
Telomerase
1
2016
26
0.030
Why?
Vaccines, Subunit
1
2016
15
0.030
Why?
Ontario
1
2016
49
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Diet
1
2020
568
0.030
Why?
Signal Transduction
1
2023
1624
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
82
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
118
0.030
Why?
S100 Proteins
1
2015
33
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
62
0.030
Why?
Cell Count
1
2015
150
0.030
Why?
Cell Hypoxia
1
2015
82
0.030
Why?
Pressure
1
2015
104
0.030
Why?
Drug Evaluation, Preclinical
1
2015
145
0.030
Why?
Blood Vessels
1
2015
71
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
46
0.030
Why?
Genetic Predisposition to Disease
1
2018
511
0.030
Why?
Random Allocation
1
2015
289
0.030
Why?
Immunoenzyme Techniques
1
2014
137
0.030
Why?
Prospective Studies
1
2020
2378
0.030
Why?
Radiotherapy Dosage
1
2015
248
0.030
Why?
Apoptosis
1
2020
1097
0.030
Why?
Proteome
1
2016
169
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
231
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
181
0.030
Why?
Likelihood Functions
1
2014
55
0.030
Why?
Anti-Bacterial Agents
1
2019
745
0.030
Why?
Multivariate Analysis
1
2015
583
0.030
Why?
Vaccination
1
2016
280
0.030
Why?
Genes, erbB-1
1
2013
8
0.030
Why?
Lipid Metabolism
1
2014
175
0.030
Why?
Gene Frequency
1
2013
97
0.030
Why?
SEER Program
1
2013
94
0.030
Why?
Adiposity
1
2014
137
0.030
Why?
Communication
1
2015
250
0.030
Why?
Mesentery
1
2012
32
0.030
Why?
Diet, High-Fat
1
2014
214
0.030
Why?
Insulin Resistance
1
2014
268
0.030
Why?
Research Design
1
2015
353
0.030
Why?
Rural Health Services
1
2015
169
0.030
Why?
Neoplasms, Glandular and Epithelial
1
2012
41
0.030
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.030
Why?
Pregnancy Proteins
1
2012
5
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
6
0.030
Why?
Ovary
1
2012
103
0.030
Why?
Angiopoietin-2
1
2012
15
0.030
Why?
Angiopoietin-1
1
2012
16
0.030
Why?
Socioeconomic Factors
1
2015
591
0.020
Why?
Ivermectin
1
2012
9
0.020
Why?
Antiparasitic Agents
1
2012
10
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
30
0.020
Why?
Infant
1
2020
3628
0.020
Why?
Algorithms
1
2015
625
0.020
Why?
Hydatidiform Mole
1
2011
2
0.020
Why?
RNA, Messenger
1
2014
1089
0.020
Why?
Crohn Disease
1
2012
93
0.020
Why?
Interleukin-6
1
2012
261
0.020
Why?
Isoenzymes
1
2011
168
0.020
Why?
Promoter Regions, Genetic
1
2012
465
0.020
Why?
Gene Expression
1
2012
610
0.020
Why?
Risk Assessment
1
2015
1270
0.020
Why?
Radiography
1
2011
485
0.020
Why?
Cell Line
1
2012
988
0.020
Why?
Cohort Studies
1
2013
1452
0.020
Why?
DNA Methylation
1
2012
550
0.020
Why?
Rats
1
2014
3292
0.020
Why?
Blotting, Western
1
2006
578
0.020
Why?
Myocardium
1
2006
445
0.010
Why?
Age Factors
1
2006
1110
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description